RECURRENT LARYNGEAL CARCINOMA

Clinical trials for RECURRENT LARYNGEAL CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new RECURRENT LARYNGEAL CARCINOMA trials appear

Sign up with your email to follow new studies for RECURRENT LARYNGEAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Pill combo aims to tame recurrent head and neck cancer in rural patients

Disease control Recruiting now

This study tests whether taking three oral drugs (methotrexate, erlotinib, and celecoxib) together is safe and practical for people with head and neck cancer that has come back or spread. The trial enrolls 25 adults in the rural Midwest and uses virtual visits to reduce travel bu…

Matched conditions: RECURRENT LARYNGEAL CARCINOMA

Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control

Last updated May 15, 2026 09:27 UTC

RECURRENT LARYNGEAL CARCINOMA

Get alerted when new RECURRENT LARYNGEAL CARCINOMA trials appear

Pill combo aims to tame recurrent head and neck cancer in rural patients